Nexalin Technology, Inc.: Nexalin Technology Announces UCSD IRB Approval for use of HALO Clarity in Clinical Trials for mTBI and PTSD Treatment
Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the "Company" or "Nexalin") the leader in Deep Intracranial Frequency Stimulation (DIFS) of the brain, announces ...
Nexalin Technology’s HALO Clarity headset approved for use in trials by UCSD
Nexalin Technology (NXL) has received Institutional Review Board – IRB – approval from the University of California, San Diego, or UCSD, for ...
Nexalin Technology Announces UCSD IRB Approval for use of HALO™ Clarity in Clinical Trials for mTBI and PTSD Treatment
Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency ...